Akero Therapeutics Inc.

NASDAQ: AKRO · Real-Time Price · USD
49.42
-0.67 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
48.69
-1.48%
After-hours: Aug 15, 2025, 07:10 PM EDT

Akero Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-70.5M -70.72M -70.02M -72.7M -55.99M -53.34M -55.19M -39.66M -31.08M -25.83M -23.06M -35.54M -27.4M -26.03M -32.42M -24.33M -28.93M -15.09M
Depreciation & Amortization
-2.67M -2.29M 15K -10.11M 1K 1K 2K 5K 11K 11K 10K 11K 11K 11K 11K 9K 10K 11K
Stock-Based Compensation
9.05M 8.78M 7.18M 7.47M 7.66M 7.4M 6.12M 5.74M 4.8M 4.84M 4.04M 11.73M 4.16M 3.31M 2.64M 2.61M 2.44M 2.36M
Other Working Capital
13.29M -5.42M 14.72M -16.76M -7.98M 6.62M 8.16M -14.05M 2.28M 631K -8.39M -162K 1.23M 1.9M 2.74M 2.17M 8.52M -6.98M
Other Non-Cash Items
198K 168K -2.87M 11.11M -2.24M -2.27M -8.2M 175K 170K -612K 218K 191K 70K 179K 52K 51K 50K 50K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 4.71M -3.27M -1.44M n/a n/a n/a n/a n/a 479K 289K 182K 121K
Change in Working Capital
15.68M -3.61M -1.39M -6.19M -6.88M 13.07M 3.93M -12.71M 5.16M -3.04M -6.72M -1.01M 3.62M -348K 2.54M 6.76M 6.22M -5.8M
Operating Cash Flow
-48.25M -67.66M -67.09M -70.42M -57.45M -35.14M -48.63M -49.72M -22.39M -24.63M -25.51M -24.62M -19.51M -22.88M -26.7M -14.61M -20.03M -18.35M
Capital Expenditures
n/a n/a n/a n/a -999K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-75.68M -583.3M -79.73M -57.93M -339.41M -38.98M -58.21M -161.2M -188.8M -24.91M -101.45M n/a n/a n/a n/a -11.91M -31.65M n/a
Sales Maturities Of Investments
155.02M 101.12M 95M 131M 84.51M 96.83M 71M 35.5M 60.5M 42.5M 1K 3M 11.87M 22.75M 12M 33.84M 21M 19M
Other Investing Acitivies
n/a n/a n/a n/a -999K n/a n/a n/a -128.3K 17.59K -101.44K 3K 11.87M 22.75M 12M 21.93M -10.65M 19M
Investing Cash Flow
79.34M -482.18M 15.27M 73.07M -255.9M 57.85M 12.79M -125.7M -128.3M 17.59M -101.44M 3M 11.87M 22.75M 12M 21.93M -10.65M 19M
Debt Repayment
n/a n/a -10M n/a n/a 10M n/a n/a n/a 15M n/a n/a 10M n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 280K n/a n/a n/a 373K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a -336.86M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 441.43M n/a n/a 1.5M 336.86M n/a 1.43M 153K 2.72M 1.7M 24.88M 132K 243K 69K 266K 24K
Financial Cash Flow
3.43M 395.53M 75.99M 3.07M -150K 366.94M 502K 806K 336.86M 15.15M 2.72M 217.9M 34.88M 132K 243K 69K 266K 24K
Net Cash Flow
34.53M -154.32M 24.17M 5.71M -313.5M 389.65M -35.34M -174.61M 186.16M 8.11M -124.23M 196.28M 27.24M 6K -14.45M 7.4M -30.42M 678K
Free Cash Flow
-48.25M -67.66M -67.09M -70.42M -58.45M -35.14M -48.63M -49.72M -22.39M -24.63M -25.51M -24.62M -19.51M -22.88M -26.7M -14.61M -20.03M -18.35M